More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis (ETP-PR) (ETP-PR)

More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis

Taking into account the recommendations of the Health Authority [1] and the application of patients' associations, we have structured a course of therapeutic education includes three stages for patients with rheumatoid arthritis and followed at Nantes University Hospital. Step 1: initial interview with a nurse patient education for diagnosis and education with the patient to choose three subjects from among 10 offered him problematic; Step 2: Orientation in an educational path that provides access to 6 months group workshops (3 maximum) and / or interviews tailored to the three selected topics; Step 3: final interview with a nurse said therapeutic education formative assessment to take stock. The main objective of our work is to ensure that the patient finds it easier solutions to the three problematic topics him after 6 months of education after six months without treatment.

Study Overview

• Status: Terminated
• Conditions: Rheumatoid Arthritis
• Intervention / Treatment: Other: immediate therapeutic education; Other: therapeutic education delayed

• Study Type: Interventional
• Enrollment (Actual): 62
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Nantes, France, 44000
    • Maugars

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patient presenting at clinics for Rheumatology or the Rheumatology Day Hospital at the University Hospital or hospitalized in the department of Rheumatology
• Men or women
• Having signed the consent
• major
• Affiliated to social security or covered by the CMU
• Patient with rheumatoid arthritis meeting the ACR criteria
• Patient with rheumatoid arthritis stable for at least 6 months (change in DAS 28 <1.2)

Exclusion Criteria:

• Patient can not understand the information
• Patient confined to bed or chair, unable to care for himself or not doing with difficulty
• pregnant patient
• minors
• Adults under guardianship

Study Plan

How is the study designed?

Design Details

• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Immediate Education therapeutic; Access to the course of immediate therapeutic education	Other: immediate therapeutic education; Access to the course of immediate therapeutic education
Other: therapeutic education delayed; Group receiving therapeutic education 6 months later (control group)	Other: therapeutic education delayed; Group receiving therapeutic education 6 months later (control group)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
EVA measures the overall ability to find solutions applicable to their situation	Investigate whether, overall, the patient is more easily applicable solutions to the situation after six months of therapeutic education after six months without therapeutic education for three problems identified after the initial filling of the questionnaire (controls ) and after the initial interview with the nurse (test group)	12 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
EVA measures the ability to find solutions applicable to their situation for each of the three problems identified.	Ability to find solutions applicable to their situation for each of the three problems identified	12 months
Knowledge (score / 10) treatments for rheumatoid arthritis, knowledge (note/10) signs of a flare of rheumatoid arthritis.	Skills that we consider indispensable	12 months
Self-efficacy against a disease flare (EVA), self-efficacy against a side effect of treatment (EVA)	Perceived self-efficacy compared to rheumatoid arthritis	12 months
RAPID score 4 (scale)	Scalability of rheumatoid arthritis	12 months
EVA measuring fatigue	Fatigue	12 months
Duration of morning stiffness in minutes or hours.	Duration of stiffness	12 months
CRP and VS	Biological criteria	12 months
Scale of STAI S Scale of STAI S	Anxiety	12 months
Beck Scale	Depression	12 months
Evaluation Test of adherence of Girerd	Observance	12 months
Dosage Cortancyl or Solupred.	Use of steroids	12 months
Number of visits to physician, rheumatologist at at therapist, psychiatrist, occupational physician, number of hospitalizations, number of meetings with occupational therapist, social worker, dietician, physiotherapist, psychologist...	Consumption of medical and paramedical	12 months
Patient satisfaction with respect to information received, the caller and the improvement in different areas of health (EVA)	Satisfaction with patient education	12 months
Attendance at meetings / workshops offered after the initial diagnosis.	Membership	12 months

Collaborators and Investigators

• Sponsor: Nantes University Hospital
• Investigators: Principal Investigator: Yves Maugars, PU-PH, CHU de Nantes

Study record dates

Study Major Dates

• Study Start: September 1, 2011
• Primary Completion (Actual): February 1, 2012
• Study Completion (Actual): February 1, 2012

Study Registration Dates

• First Submitted: March 21, 2012
• First Submitted That Met QC Criteria: March 23, 2012
• First Posted (Estimate): March 27, 2012

Study Record Updates

• Last Update Posted (Estimate): August 8, 2016
• Last Update Submitted That Met QC Criteria: August 5, 2016
• Last Verified: August 1, 2016

More Information

Terms related to this study

• Keywords: Therapeutic Education, Rheumatoid Arthritis
• Additional Relevant MeSH Terms: Immune System Diseases; Autoimmune Diseases; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Arthritis; Arthritis, Rheumatoid
• Other Study ID Numbers: BRD/11/02-J